Showing 1 - 1 of 1
The fervent global quest for the development of a vaccine against the novel coronavirus (COVID-19) begs the frightening questions: who will go first in receiving it? and will everyone get to receive it at all? This working paper seeks to highlight the risk that mercantilist market-logic...
Persistent link: https://www.econbiz.de/10014097182